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BACKGROUND: Obesity is one of the most important risk factors for or above the ischial spine, and affixed to the vaginal apex. Delayed
the development and progression of the pelvic organ prolapse. However,
data regarding whether obesity is a risk factor for recurrence after pelvic
organ prolapse surgery are controversial.
OBJECTIVE: The aim of this study was to estimate the risk of
recurrent prolapse in any vaginal compartment after total vaginal hys-
terectomy with concurrent uterosacral ligament vaginal vault suspension
among normal-weight women compared with either overweight or obese
women.
STUDYDESIGN: This is a 5-year retrospective cohort study of women
who underwent total vaginal hysterectomy with concurrent vaginal ute-
rosacral ligament suspension at one referral center for pelvic organ
prolapse in Italy from January 2010 to January 2015. All women who
underwent total vaginal hysterectomy with concurrent uterosacral liga-
ment suspension were included in the analysis. Laparoscopic approach
was excluded. Women were classified according to the body mass index of
2 groups: (1) normal weight (body mass index, 18.5e24.9 kg/m2) and (2)
either overweight (body mass index, 25.0e29.9 kg/m2) or obese (body
mass index, 30.0 kg/m2). The primary outcome was the incidence of
recurrent prolapse in any vaginal compartment (anterior, posterior, or
apical). Recurrent prolapse was defined as prolapse extending beyond the
hymen with straining (pelvic organ prolapse quantification points Ba, C, Bp
0) or repeat treatment for prolapse with either pessary or surgery.
Uterosacral ligament suspensions were performed with a vaginal approach
with the use of sutures placed in the intermediate uterosacral ligament, atCite this article as: Rappa C, Saccone G. Recurrence of
vaginal prolapse after total vaginal hysterectomy with
concurrent vaginal uterosacral ligament suspension:
comparison between normal-weight and overweight
women. Am J Obstet Gynecol 2016;215:601.e1-4.
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http://dx.doi.org/10.1016/j.ajog.2016.06.022absorbable sutures were used, with 2 sutures per side.
RESULTS: Three hundred sixty women who underwent total vaginal
hysterectomy with concurrent uterosacral ligament suspension with at least
6 months of follow up after surgery were included in the study. The overall
incidence of recurrent prolapse in any vaginal compartment was 19.7%
(71/360 women). The risk of recurrent prolapse in any vaginal compart-
ment (ie, primary outcome) was similar in the normal-weight compared with
the overweight or obese group (16.7% vs 21.3%; P¼.30). Women in the
normal-weight group had a lower risk of recurrent anterior vaginal prolapse
(10.8% vs 20.0%; adjusted odds ratio, 0.49; 95% confidence interval,
0.25e0.94) and of multiple compartment prolapse (8.3% vs 14.6%;
adjusted odds ratio, 0.53; 95% confidence interval, 0.31e0.83).
CONCLUSION: After total vaginal hysterectomy with concurrent ute-
rosacral ligament suspension, the risk of recurrent vaginal prolapse was
20% based on a composite outcome definition of any anatomic prolapse
beyond the hymen or pessary or repeat surgery. The most common site of
recurrence was the anterior compartment. The risk of recurrent surgery
was 10%. Our study showed that women with normal-weight had similar
risk of recurrent prolapse compared with the overweight or obese group. In
subgroup analyses, women with normal-weight had one-half the odds of
recurrent anterior vaginal wall prolapse compared with those who were
overweight or obese.
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prolapse, is 1 of the most frequent
gynecologic procedures performed in
the United States.1,2 The vaginal route
is the most cost-effective approach for
a hysterectomy performed for uterova-
ginal prolapse.1 Vaginal hysterectomy
with concurrent uterosacral ligamentsuspension is a common, safe, and cost-
effective procedure for prolapse.3 A
recent systematic review with meta-
analysis showed that uterosacral liga-
ment suspension is a highly effective
procedure for the restoration of apical
vaginal support, with a successful rate of
approximately 80%.4
Obesity is 1 of themost important risk
factors for the development and pro-
gression of pelvic organ prolapse.5
However, data regarding whether
obesity is a risk factor for recurrence
after pelvic organ prolapse surgery are
controversial.6-11
Therefore, the aim of this study was to
estimate the risk of recurrent prolapse in
any vaginal compartment after total
vaginal hysterectomy with concurrentNOVEMBER 2016 Ameriuterosacral ligament vaginal vault sus-
pension among normal-weight women
compared with overweight or obese
women.
Materials and Methods
This was a 5-year retrospective cohort
study of women who underwent total
vaginal hysterectomy with concurrent
uterosacral ligament suspension at 1
referral center in Naples, Italy (Depart-
ment of Obstetrics and Gynecology,
Ospedale Buon Consiglio Fate-
benefratelli) from January 2010 to
January 2015. In this center, vaginal
hysterectomy with concurrent utero-
sacral ligament suspension is the
preferred approach in cases of pelvic
organ prolapse.can Journal of Obstetrics& Gynecology 601.e1
FIGURE
Study algorithm
The strengthening the reporting of the obser-
vational studies in epidemiology (STROBE)
template.
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criteria, primary outcome, and sample
size calculations were based on a similar
previously published study.6
Clinical records of women who were
referred for uterovaginal prolapse were
collected prospectively in a dedicated
database. All charts that were recorded in
the database were reviewed carefully by
the 2 authors. All variables that were
reported were collected on all of the
patients who were included in this study.
The study was approved by the local
institutional review board, which also
checked the quality of the dataset. Data
were anonymized before analysis.
All women who underwent total
vaginal hysterectomy with concurrent
vaginal uterosacral ligament suspension
were included in the analysis. Women
with history of previous vault suspension
and those with <6 months of follow up
were excluded. Laparoscopic approach
and women with previous hysterectomy
were also excluded.
Women were classiﬁed in 2 groups
according to the body mass index (BMI;
calculated as weight [kg]/height [m2]):
normal weight (BMI, 18.5e24.9 kg/m2)
and either overweight (BMI, 25.0-29.9
kg/m2) or obese (BMI, 30.0 kg/m2).
We planned to assess the primary
outcome in a subanalysis across all 3
BMI groups. Only the primary outcome
was assessed in the subanalysis.
Primary and secondary outcomes
were designed a priori. The primary
outcome was the incidence of recurrent
prolapse in any vaginal compartment
(anterior, posterior, or apical). Recurrent
prolapse was deﬁned as prolapse that
extended beyond the hymen with
straining (pelvic organ prolapse quanti-
ﬁcation points Ba, C, Bp 0) or repeat
treatment for prolapse with either pes-
sary or surgery. The secondary outcomes
were incidence of anterior prolapse,
posterior prolapse, and apical prolapse.
Incidence of multiple compartment
prolapse, deﬁned as a combination of
recurrent prolapse in >1 compartment,
was also assessed.
During this 5-year period, all total
hysterectomies and uterosacral ligament
suspensions were performed with a
vaginal approach with the use of sutures601.e2 American Journal of Obstetrics& Gynecolthat were placed in the intermediate
uterosacral ligament, at or above the
ischial spine, and afﬁxed to the vaginal
apex as previously described by Shull
et al.12 In all the procedures, delayed
absorbable sutures were used, with 2
sutures per side.
Statistical analysis was performedwith
Statistical Package for Social Sciences
(SPSS) software (version 19.0; IBM Inc,
Armonk, NY). Data were shown as
meansstandard deviation or as num-
ber (percentage). Categoric variables
were compared with the use of the chi-
square or Fisher’s exact test. Contin-
uous variables were compared with the
use of Wilcoxon and Mann-Whitney
tests for nonparametric data. Para-
metric analysis was assessed to test group
means with standard deviation for
parametric data. Probability values of
<.05 was considered statistically signiﬁ-
cant. Logistic regression, presented as
adjusted odds ratio (aOR) with the 95%
of conﬁdence interval (CI), was per-
formed to correct data for those vari-
ables signiﬁcantly different between the
2 groups.
Sample size calculations were assessed
a priori and were based on previously
published data.6 We observed that with
an a of .05 and 80% power, a sample size
of approximately 360 women (120
normal-weight and 240 either over-
weight or obese women) was required to
detect a 30% difference in the recurrence
of prolapse.
The study was performed according to
the strengthening the reporting of the
observational studies in epidemiology
(STROBE) guidelines.13
Results
Data for 360womenwhounderwent total
vaginal hysterectomy with concurrent
vaginal uterosacral ligament suspension
with at least 6 months follow-up after
surgery were analyzed (Figure). Table 1
shows the characteristics of the women
who were included. Of the 360 women,
120 had normal weight (mean BMI,
22.11.2 kg/m2), and 240 were over-
weight or obese (meanBMI, 30.74.4 kg/
m2). Compared with the overweight or
obese group, the normal-weight cohort
had less incidence of smoking (10.0% vsogy NOVEMBER 201630.0%; P¼.02) and constipation (27.5%
vs 40.0%; P¼.03). The follow-up interval
was similar. Forty-two women in the
normal-weight group and 79 in the
overweight or obese group received a
concomitant stress urinary incontinence
procedure.14 Regarding the intra-
operative and postoperative complica-
tions, among the total cohort, there were
5 urinary tract injuries (1.4%; 2 cystoto-
mies [0.6%] and 3 ureteral injuries
[0.8%]). No women required blood
transfusion. One women in the normal-
weight group reported neuropathic pain
8 months after the procedure.
Regarding the primary outcome, the
overall incidence of recurrent prolapse in
any vaginal compartment (anterior, pos-
terior, or apical) was 19.7% (71/360
women). The risk of recurrent prolapse in
any vaginal compartment was similar in
the normal-weight group compared with
the overweight or obese group (16.7% vs
21.3%; P¼.30). The risk of repeat surgery
was 10.0% (36/360 women). The risk
among normal-weight (10/120 women;
8.3%) was similar compared with the risk
in the overweight or obese group (26/240
women; 10.8%; P¼.11).
TABLE 1
Characteristics of the included women
Variables
Normal-weight
(n¼120; 33.3%)
Overweight
or obese
(n¼240; 66.7%) P value
Body mass index group, n (%) —
Normal weight 120 (100) —
Overweight — 140 (58.3)
Obese — 100 (41.7)
Mean body mass index, kg/m2SD 22.11.2 30.74.4 <.01a
Mean age, ySD 69.15.7 69.511.4 .14b
Ethnicity, n (%) .33b
White 115 (95.8) 236 (98.3)
Non-whitec 5 (4.2) 4 (1.7)
Nulliparous, n (%) 37 (30.8) 70 (29.2) .77b
Multiparous, n (%) 83 (69.2) 170 (70.8) .77b
Current tobacco use, n (%) 12 (10.0) 72 (30.0) .02a
Chronic hypertension, n (%) 15 (12.5) 31 (12.9) .81b
Diabetes mellitus, n (%) 9 (7.5) 17 (7.1) .69b
Constipation, n (%) 33 (27.5) 96 (40.0) .03a
Pulmonary disease, n (%) 7 (5.8) 13 (5.4) .90b
Previous pelvic organ prolapse
surgery, n (%)
6 (5.0) 11 (4.6) .77b
Preoperative pelvic organ prolapse
quantification stage, n (%)
.22b
1 0 2 (0.8)
2 42 (35.0) 80 (33.3)
3 75 (62.5) 150 (62.5)
4 3 (2.5) 8 (3.4)
Concurrent anterior repair, n (%) 90 (75.0) 187 (77.9) .12b
Concurrent posterior repair, n (%) 66 (55.0) 131 (54.6) .34b
Concurrent stress urinary continence
procedure, n (%)
42 (35.0) 79 (32.9) .17b
Estimated blood loss, mL .41b
MeanSD 131  77 121  61
Median (interquartile range) 100 (100e200) 100 (100e200)
Operative time, min .07b
MeanSD 83.314.5 94.711.2
Median (interquartile range) 85 (60e110) 91 (68e121)
Median follow-up time, mo
(interquartile range)
13 (7.5e25.5) 12 (8.0e28.0) .94b
a Statistically significant; b Not significant; c Non-white ethnicity, including Hispanic, Asiatic, and Black African.
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both groups. The anterior compartment
was the 1 compartment at most risk of
recurrent prolapse. After adjusting for
confounders that were proved statisti-
cally (ie, smoking and constipation), we
found that women in the normal-weight
cohort had a lower risk of recurrent
anterior vaginal prolapse (10.8% vs
20.0%; aOR, 0.49; 95% CI, 0.25e0.94)
and of multiple compartment prolapse
(8.3% vs 14.6%; aOR, 0.53; 95% CI,
0.31e0.83); no differences were found in
the risk of overall recurrence (16.7% vs
21.3%; aOR, 0.78; 95% CI, 0.49e1.25),
apical (8.3% vs 9.6%; aOR, 0.87; 95%CI,
0.43e1.77), and posterior prolapse
(5.8% vs 6.3%; aOR, 0.93; 95% CI,
0.39e2.23). Subanalysis across all 3 BMI
cohorts showed no differences in the risk
of recurrent prolapse in any vaginal
compartment (anterior, posterior, or
apical) comparing the normal-weight
group (20/120 women; 16.7%) with the
overweight (28/140 women; 20.0%) and
the obese group (23/100 women; 23.0%;
P¼.27).
Comment
This retrospective cohort study showed
that, with at least 6 months of follow up
after total vaginal hysterectomy with
concurrent vaginal uterosacral ligament
suspension, the risk of recurrent vaginal
prolapse was 20%, based on a composite
outcome deﬁnition of any anatomic
prolapse beyond the hymen or pessary or
repeat surgery. Themost common site of
recurrence was the anterior compart-
ment. The risk of recurrent surgery was
10%. Our study showed that women in
the normal-weight group had similar
risk of recurrent prolapse compared with
the overweight or obese group. However,
subgroup analyses showed that women
with normal weight had a lower risk of
anterior vaginal prolapse of approxi-
mately 51% compared with overweight
or obese women.
Our study has several strengths. This
is a large 5-year study. The number of the
included women was very high. To our
knowledge, no previous study on this
issue is as large or comprehensive.
Logistic regression was performed to
correct data for those variables thatwere signiﬁcantly different between
the 2 groups. Strengthening the report-
ing of the observational studies inNOVEMBER 2016 AmeriEpidemiology (STROBE) guidelines
were followed strictly.13 Subgroup ana-
lyses were established a priori. These arecan Journal of Obstetrics& Gynecology 601.e3
TABLE 2
Primary and secondary outcomes
Site of recurrence
Normal-weight
(n¼120; 33.3%), n (%)
Overweight
or obese
(n¼240; 66.7%), n (%) P value
Overall recurrencea 20 (16.7) 51 (21.3) .30b
Apical 10 (8.3) 23 (9.6) .24b
Anterior 13 (10.8) 48 (20.0) .03c
Posterior 7 (5.8) 15 (6.3) .15b
Multiple compartment 10 (8.3) 35 (14.6) .01c
Recurrent prolapse was defined as prolapse extending beyond the hymen with straining (pelvic organ prolapse quantification
points Ba, C, Bp 0) or repeat treatment for prolapse with either pessary or surgery.
a Primary outcome; b Not significant; c Statistically significant.
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the reliability of a study.15
The most important limitation of our
study is that this is a retrospective,
nonrandomized comparison. We do
acknowledge that the subgroup analysis
was underpowered, which is a major
weakness of this study; however, this is
indeed an uncommon cohort of women.
Our outcomes did not include an
assessment of prolapse symptoms. No
subjective outcomes were reported;
anatomic ﬁndings and retreatment were
used to deﬁne recurrent prolapse. All
procedures were performed with the use
of 2 delayed absorbable sutures per side;
therefore, assessment of the risk of
recurrent prolapse according to the type
of sutures (eg, delayed absorbable vs
permanent suture) or to the number of
suture (eg, 1 per side, 2 per side, or
another combination) was not feasible.
Edenﬁeld et al6 showed that, after
uterosacral ligament suspension,
normal-weight women had similar
anterior prolapse recurrence compared
with overweight or obese women. They
found a nonsigniﬁcant reduction in the
normal-weight group regarding the
anterior compartment prolapse. How-
ever, their data probably did not reach
statistical signiﬁcance because of a type
II error (number of women included,
219).6 Conversely, Diez-Itza et al9
showed an increased risk of anterior601.e4 American Journal of Obstetrics& Gynecolprolapse recurrence after vaginal surgery
with increase bodyweight. Our ﬁndings
add to the literature because previous
studies did not investigate speciﬁcally
total vaginal hysterectomy with concur-
rent vaginal uterosacral ligament sus-
pension, included also women without
hysterectomy, and the sample size were
smaller.6-11
In conclusion, after uterosacral liga-
ment suspension, overweight or obese
women have a similar overall risk of pro-
lapse recurrence but may be more prone
to recurrence in the anterior wall com-
pared with normal-weight women. n
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